TIP767: Mastermind Discussion Q4 2025: Sanofi, Remitly & Crocs w/ Stig Brodersen, Tobias Carlisle, and Hari Ramachandra
The episode is a quarterly mastermind discussion where Stig Brodersen, Tobias Carlisle, and Hari Ramachandra each pitch an investment idea and stress-test each other's theses. Hari presents Sanofi as a relatively cheap, dividend-paying global biopharma with durable vaccine and immunology franchises that he views as a "T-bill with growth" type holding. Stig analyzes Remitly, a fast-growing digital remittance platform, weighing its strong unit economics and underbanked niche against strategic drift, intense competition, and heavy stock-based compensation, while Toby pitches Crocs as a deeply undervalued, cash-generative footwear brand facing fashion, tariff, and acquisition risks but offering significant upside if issues are managed.
Advice Line with Randy Hetrick of TRX
Host Guy Raz speaks with TRX founder Randy Hetrick on an 'Advice Line' episode where they take calls from three founders seeking guidance on scaling their businesses. Randy first updates listeners on his journey selling TRX to private equity, starting a new outdoor fitness venture, and eventually buying TRX back in a turnaround. Together, Guy and Randy advise the founders of an emerging low-caffeine energy drink brand entering Target, an Australian meat pie franchise looking for strategic investment, and an adaptive apparel company debating how narrowly to focus its target markets.